PDB Information

PDB6GL9
MethodX-RAY DIFFRACTION
Host OrganismSpodoptera frugiperda
Gene SourceHomo sapiens
Primary Citation
Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4- d]pyrrolo[2,3- b]pyridine Scaffold.
Forster, M., Chaikuad, A., Dimitrov, T., Doring, E., Holstein, J., Berger, B.T., Gehringer, M., Ghoreschi, K., Muller, S., Knapp, S., Laufer, S.A.
J. Med. Chem.
HeaderTransferase
Released2018-05-23
Resolution1.700
CATH Insert Date06 Jul, 2018

PDB Images (7)

PDB Prints

PDB Chains (2)

Chain ID Date inserted into CATH CATH Status
A 06 Jul, 2018 Chopped
B 06 Jul, 2018 Chopped

CATH Domains (4)

Domain ID Date inserted into CATH Superfamily CATH Status
6gl9A01 19 Jul, 2018 3.30.200.20 Assigned
6gl9A02 19 Jul, 2018 1.10.510.10 Assigned
6gl9B01 19 Jul, 2018 3.30.200.20 Assigned
6gl9B02 19 Jul, 2018 1.10.510.10 Assigned

UniProtKB Entries (2)

Accession Gene ID Taxon Description
P52333 JAK3_HUMAN Homo sapiens Tyrosine-protein kinase JAK3
P52333 JAK3_HUMAN Homo sapiens Tyrosine-protein kinase JAK3